emoxypine succinate has been researched along with Diabetic Neuropathies in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shishkova, VN | 1 |
| Miroshnichenko, IIu; Rassokhina, LM; Volchegorskiĭ, IA | 1 |
| Chashchina, EN; Moskvicheva, MG; Volchegorskiĭ, IA | 1 |
| Gnezdilov, AV; Medvedeva, LA; Samoĭlova, NV; Slashchuk, IuI; Syrovegin, AV; Zagorul'ko, OI | 1 |
1 review(s) available for emoxypine succinate and Diabetic Neuropathies
| Article | Year |
|---|---|
[Specific features of neurological complications developing in patients with type 2 diabetes mellitus and metabolic syndrome: possibility for correction and prevention].
Topics: Antioxidants; Cognition Disorders; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Neuropathies; Endothelium, Vascular; Humans; Metabolic Syndrome; Oxidative Stress; Picolines | 2015 |
1 trial(s) available for emoxypine succinate and Diabetic Neuropathies
| Article | Year |
|---|---|
[Neurometabolic therapy of diabetic neuropathy].
Topics: Adjuvants, Immunologic; Analgesics, Non-Narcotic; Antioxidants; Blood Glucose; Carbamazepine; Diabetic Neuropathies; Drug Therapy, Combination; Follow-Up Studies; Humans; Middle Aged; Pain; Pentoxifylline; Picolines; Thiamine; Thioctic Acid; Treatment Outcome; Vasodilator Agents | 2006 |
2 other study(ies) available for emoxypine succinate and Diabetic Neuropathies
| Article | Year |
|---|---|
[Antihypoxic effect of 3-hydroxypyridine and succinic acid derivatives and their nootropic action in alloxan diabetes].
Topics: Alloxan; Animals; Conditioning, Classical; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Dose-Response Relationship, Drug; Female; Hyperglycemia; Hyperlipidemias; Hypoxia; Male; Meglumine; Mice; Nootropic Agents; Picolines; Pyridines; Rats; Succinates; Thioctic Acid | 2011 |
[An effect of antioxidant drugs on symptoms of sensomotor polyneuropathy and affective disorders in patients with diabetes mellitus].
Topics: Aged; Antioxidants; Anxiety Disorders; Data Interpretation, Statistical; Depressive Disorder; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Female; Follow-Up Studies; Humans; Hypoglycemic Agents; Male; Middle Aged; Picolines; Psychotropic Drugs; Time Factors; Treatment Outcome | 2005 |